These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35241461)

  • 1. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
    Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
    Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
    Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.
    Keane A; Ng CW; Simms KT; Nguyen D; Woo YL; Saville M; Canfell K
    Int J Cancer; 2021 Dec; 149(12):1997-2009. PubMed ID: 34363620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023.
    Hariprasad R; Bagepally BS; Kumar S; Pradhan S; Gurung D; Tamang H; Sharma A; Bhatnagar T
    PLoS One; 2024; 19(8):e0300556. PubMed ID: 39137206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's acceptability of a self-collect HPV same-day screen-and-treat program in a high burden setting in the Pacific.
    Camara H; Nosi S; Munnull G; Badman SG; Bolgna J; Kuk J; Mola G; Guy R; Vallely AJ; Kelly-Hanku A
    BMC Health Serv Res; 2022 Dec; 22(1):1514. PubMed ID: 36510192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study.
    Shi JF; Canfell K; Lew JB; Zhao FH; Legood R; Ning Y; Simonella L; Ma L; Kang YJ; Zhang YZ; Smith MA; Chen JF; Feng XX; Qiao YL
    BMC Cancer; 2011 Jun; 11():239. PubMed ID: 21668946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis.
    Choi HCW; Leung K; Chan KKL; Bai Y; Jit M; Wu JT
    BMC Med; 2023 Feb; 21(1):48. PubMed ID: 36765349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
    Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
    Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study.
    Zhao XL; Zhao S; Xia CF; Hu SY; Duan XZ; Liu ZH; Wang YY; You TT; Gao M; Qiao YL; Basu P; Zhao FH
    BMC Med; 2023 Apr; 21(1):149. PubMed ID: 37069602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.
    Toliman PJ; Kaldor JM; Badman SG; Gabuzzi J; Silim S; Kumbia A; Kombuk B; Kombati Z; Munnull G; Guy R; Vallely LM; Kelly-Hanku A; Wand H; Ryan C; Tan G; Brotherton J; Saville M; Mola GDL; Garland SM; Tabrizi SN; Vallely AJ
    Papillomavirus Res; 2018 Dec; 6():70-76. PubMed ID: 30391365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
    Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
    Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
    PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
    Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
    Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
    Simms KT; Keane A; Nguyen DTN; Caruana M; Hall MT; Lui G; Gauvreau C; Demke O; Arbyn M; Basu P; Wentzensen N; Lauby-Secretan B; Ilbawi A; Hutubessy R; Almonte M; De Sanjosé S; Kelly H; Dalal S; Eckert LO; Santesso N; Broutet N; Canfell K
    Nat Med; 2023 Dec; 29(12):3050-3058. PubMed ID: 38087115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
    Kositamongkol C; Kanchanasurakit S; Mepramoon E; Talungchit P; Chaopotong P; Kengkla K; Chaisathaphol T; Saokaew S; Phisalprapa P
    BMC Public Health; 2023 Dec; 23(1):2413. PubMed ID: 38049773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.